Report Content
Chapter 1 Methodology & Scope
1.1 Market scope & definition
1.2 Base estimates & calculations
1.3 Data validation
1.4 Data collection
1.5 Forecast parameters
1.6 Data sources
1.6.1 Primary
1.6.2 Secondary
1.6.2.1 Paid sources
1.6.2.2 Unpaid sources
Chapter 2 Executive Summary
2.1 Industry 3600 synopsis
Chapter 3 Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Increasing demand for biopharmaceuticals
3.2.1.2 Growing adoption of continuous bioprocessing among CMOs and CDMOs
3.2.1.3 Advancements in continuous bioprocessing technologies
3.2.2 Industry pitfalls & challenges
3.2.2.1 High equipment cost
3.2.2.2 Stringent regulatory requirements
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Porter's analysis
3.5.1 Supplier power
3.5.2 Buyer power
3.5.3 Threat of new entrants
3.5.4 Threat of substitutes
3.5.5 Industry rivalry
3.6 PESTEL analysis
Chapter 4 Competitive Landscape, 2023
4.1 Introduction
4.2 Company matrix analysis
4.3 Company market share analysis
4.4 Competitive positioning matrix
4.5 Strategy dashboard
Chapter 5 Market Estimates and Forecast, By Product, 2018 – 2032 ($ Mn)
5.1 Key trends
5.2 Instruments
5.2.1 Chromatography systems
5.2.2 Filtration systems and devices
5.2.3 Bioreactors
5.2.4 Other instruments
5.3 Consumables
5.3.1 Cell culture media & buffers
5.3.2 Reagents
Chapter 6 Market Estimates and Forecast, By Scale of Operation, 2018 – 2032 ($ Mn)
6.1 Key trends
6.2 Commercial
6.3 Research and development
Chapter 7 Market Estimates and Forecast, By Process, 2018 – 2032 ($ Mn)
7.1 Key trends
7.2 Downstream bioprocess
7.3 Upstream bioprocess
Chapter 8 Market Estimates and Forecast, By Application, 2018 – 2032 ($ Mn)
8.1 Key trends
8.2 Monoclonal antibodies
8.3 Vaccines
8.4 Cell and gene therapy
8.5 Other applications
Chapter 9 Market Estimates and Forecast, By End-User, 2018 – 2032 ($ Mn)
9.1 Key trends
9.2 Pharmaceutical and biotechnology companies
9.3 CMOs and CROs
9.4 Research and academic institutes
Chapter 10 Market Estimates and Forecast, By Region, 2018 – 2032 ($ Mn)
10.1 Key trends
10.2 North America
10.2.1 U.S.
10.2.2 Canada
10.3 Europe
10.3.1 Germany
10.3.2 UK
10.3.3 France
10.3.4 Spain
10.3.5 Italy
10.3.6 Rest of Europe
10.4 Asia Pacific
10.4.1 China
10.4.2 Japan
10.4.3 India
10.4.4 Australia
10.4.5 Rest of Asia Pacific
10.5 Latin America
10.5.1 Brazil
10.5.2 Mexico
10.5.3 Rest of Latin America
10.6 Middle East and Africa
10.6.1 South Africa
10.6.2 Saudi Arabia
10.6.3 Rest of Middle East and Africa
Chapter 11 Company Profiles
11.1 3M Company
11.2 Bionet
11.3 Danaher Corporation (Pall Corporation)
11.4 Eppendorf SE
11.5 FUJIFILM HOLDINGS CORPORATION
11.6 Merck KGaA
11.7 Repligen Corporation
11.8 Sartorius AG
11.9 Thermo Fisher Scientific Inc.
11.10 WuXi Biologics
